G

ANALYST NOTE: GENPACT LIMITED (G) Date: 2026-06-13 Current Price: $28.25

1. Structural Readiness

State: Context-Only Conservative Entry: — Breakout Level: — Extension: — ATR Current: 4.8% (High)

Analysis:

2. The Thesis Layer

Primary Secular Thesis: AI Infrastructure → AI Software & Applications (Tier 2 Order, Moderate Confidence) Company Role: Direct Beneficiary / Enabler

Genpact is positioned as a direct beneficiary of the secular shift toward AI Infrastructure, specifically within the AI Software & Applications layer. The company is not merely an observer but an active architect of "Agentic Operations." Management has explicitly stated that the firm is moving clients from "experimentation with AI to agentic operations," where AI systems act and learn alongside humans.

The company's role is defined by the combination of deep domain expertise (process intelligence) with AI orchestration. This creates a "second-order" exposure: while the primary infrastructure (chips, cloud) is the foundation, Genpact provides the application layer that deploys these tools into enterprise workflows. The evidence suggests a strong alignment with the thesis, as the company is building, orchestrating, and governing these agentic systems across essential business functions. The "moderate confidence" in the tier classification reflects the competitive nature of the application layer, but the directness of the beneficiary status is high, evidenced by the rapid acceleration in revenue from these specific solutions.

3. The Business

Business Model & Industry: Genpact is a global professional services firm specializing in Business Process Management (BPM) and Information Technology solutions. It operates across three primary industry segments: Financial Services (Banking, Capital Markets, Insurance), Consumer & Healthcare, and High Tech & Manufacturing. The business model relies on a hybrid of traditional process outsourcing and high-value transformational consulting, increasingly driven by proprietary AI and data analytics.

Supporting Evidence (As of 2026-06-13):

• Revenue Growth & Segmentation: In Q1 2026, Genpact reported total net revenues of $1,296.1 million, a 6.7% increase year-over-year. The Advanced Technology Solutions (ATS) segment, the core of the AI thesis, generated $345.2 million in revenue, representing a 24.3% year-over-year growth (up from $277.6 million in Q1 2025). This segment now accounts for a significant portion of the total revenue mix.
• Deal Momentum: Management reported signing 6 large deals in the quarter, with a "healthy pipeline" of other transformational deals. The total contract value of "agentic solutions" nearly doubled in the single quarter compared to the full year of 2025.
• Segment Performance:
• Financial Services: +5.4% growth, driven by data/AI solutions and deal ramp-ups.
• Consumer & Healthcare: +6.1% growth, driven by digital solutions and advisory services.
• High Tech & Manufacturing: +8.0% growth, primarily driven by agentic solutions and technology services.
• Client Base: The firm serves over 145,000 employees across 35+ countries, including major clients like Cardinal Health (transformation across finance/supply chain) and Bendigo Bank (operating model transformation).
• Service Portfolio: Beyond AI, the firm provides robust F&A services (Invoice-to-Cash, Record-to-Report), supply chain consulting, and ESG support (carbon accounting, sustainability due diligence).

4. Archetype and Conviction

Archetype: Quality Compounder Fit Analysis: Genpact fits the Quality Compounder archetype due to its consistent margin expansion and ability to reinvest earnings into high-growth, high-margin technology solutions.

• Margin Inflector: Gross margins expanded for the 12th consecutive quarter, rising from 35.3% in Q1 2025 to 36.4% in Q1 2026. This expansion, driven by a mix shift toward higher-value ATS and foreign exchange benefits, provides the capital efficiency necessary for compounding.
• Growth Leader: The company is transitioning from a traditional services model to a technology-led compounder. Management expects Advanced Technology Solutions to grow at least 20% for the full year 2026, significantly outpacing the overall company guidance of at least 7% growth on an as-reported basis.
• Valuation Context: The financial spine indicates a forward consensus EPS of $4.07 for FY1 and $4.48 for FY2. At a current price of $28.25, the stock trades at approximately 6.9x FY1 forward earnings, suggesting a valuation that reflects the transition but offers room for rerating if the 20% ATS growth is sustained.

Conviction Stack:

• Thesis Strength: High. The "Agentic" narrative is not hypothetical; it is already driving 24%+ revenue growth in the relevant segment.
• Evidence Quality: Strong. Multiple data points (earnings transcripts, 10-Q/10-K filings) corroborate the acceleration in ATS revenue and margin expansion.
• Rerating Potential: Significant. The market is currently pricing in a services company; a sustained shift to a "Technology Compounder" with 20% growth in its high-margin segment could drive multiple expansion.

5. Invalidations, Strengtheners, and Gaps

Invalidation Triggers:

• Growth Deceleration: If the Advanced Technology Solutions growth rate falls below the 20% guidance or if the overall company growth misses the 7% target significantly.
• Margin Compression: A reversal of the 12-quarter margin expansion trend, particularly if the cost of delivering AI solutions outpaces revenue growth.
• Deal Pipeline Drying Up: A significant reduction in the number of large deals signed or a contraction in the pipeline of transformational deals.

Strengtheners:

• Pipeline Conversion: Confirmation that the "healthy pipeline" of large deals converts to booked revenue at the expected pace.
• Agentic Adoption: Further evidence of clients moving from "experimentation" to full-scale "agentic operations" deployment, leading to higher contract values.
• Margin Expansion: Continued gross margin expansion beyond the 100 basis point year-over-year improvement seen in Q1.

Evidence Gaps:

• Specific AI Revenue Breakdown: While ATS is reported, the specific revenue contribution of "agentic solutions" versus general "data and AI solutions" is not fully granular in the provided text, though the doubling of contract value is a strong proxy.
• Guidance for 2027: Management provided guidance for 2026, but no forward-looking data for 2027 is available in the evidence set.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Advanced Technology Solutions revenue grew 24.3% YoY to $345.2M in Q1 2026; Gross margin expanded for 12 consecutive quarters to 36.4%; Management expects ATS to grow at least 20% for 2026. Expected path: Management expects continued strength in ATS driven by agentic solutions and data demand; structural implication is a shift in revenue mix toward higher-margin technology services. Expected horizon: 12 to 18 months for the thesis to fully play out as deal ramp-ups mature.